Journal article · 2026 · Open access

Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis

Noa Furth, Christina Riemenschneider, Yishai Arieli, Matan Avni, Michael-Yakov Povolotski, Hadas Yung, Shiri Karagach, Ofir Atrakchi, Nir Erez, Tomer-Meir Salame, Roberta Noberini, Adeline Durand and 38 more

Nature · Published 11 November 2026 · DOI 10.1038/s41586-026-11230-y

Open PDFView at the publisherCite this paper

In brief

“Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis” is a 2026 journal article by Noa Furth and 49 co-authors, published in Nature. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Nature.

Citations
0
References
126
Authors
50

Abstract

Breast cancer, the most diagnosed cancer among women, is stratified by gene expression patterns into luminal and basal-like subtypes, and the latter is associated with worse prognosis1–3. Recent advances in single-cell technologies have underscored the presence of intratumour heterogeneity, which poses substantial challenges in cancer treatment and achieving long-term disease-free survival4–7. Here we extensively profile epigenetic heterogeneity in a cohort of treatment-naive human luminal tumours, which were obtained directly after surgical resection. By applying a single-cell epigenetic approach based on cytometry by time-of-flight, we identify a recurrent subpopulation of basal-like cells in luminal tumours with a conserved epigenetic signature across patients. These basal-like cells, also identified by deconvolution of whole-genome DNA methylation patterns, are characterized by high expression of aggressive oncogenic traits and downregulation of hormone receptor signalling. Direct comparison of single-cell proteomic and genomic profiling of monomethylation and trimethylation of histone 3 on lysine 4 revealed that these marks are key features associated with loss of luminal identity. Finally, we highlight the potential of concomitant single-molecule profiling of histone modifications on cell-free nucleosomes in blood as an epigenetic liquid biopsy approach for early diagnosis of breast cancer. Moreover, the epigenetic basal signature measured in blood is linked to prognosis, which enables the identification of patients at increased risk for disease relapse. Single-cell epigenetic analyses reveal a conserved epigenetic signature across patients that may help identify those at increased risk for disease relapse in breast cancer.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Furth, N., Riemenschneider, C., Arieli, Y., Avni, M., Povolotski, M.-Y., Yung, H., Karagach, S., Atrakchi, O., Erez, N., Salame, T.-M., Noberini, R., Durand, A., Jouault, G., Dassa, B., Zerbib, M., Oren, R., Golani, O., Bar-Zakai, B., Mavor, Y., . . . Shema, E. (2026). Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis. Nature. https://doi.org/10.1038/s41586-026-11230-y

MLA 9

Furth, Noa, et al. “Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis.” Nature, 2026. https://doi.org/10.1038/s41586-026-11230-y.

Chicago

Furth, Noa, Christina Riemenschneider, Yishai Arieli, Matan Avni, Michael-Yakov Povolotski, Hadas Yung, Shiri Karagach, et al. 2026. “Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis.” Nature. https://doi.org/10.1038/s41586-026-11230-y.

Harvard

Furth, N. et al. (2026) ‘Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis’, Nature. doi:10.1038/s41586-026-11230-y.

IEEE

N. Furth et al., “Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis,” Nature, 2026, doi: 10.1038/s41586-026-11230-y.

BibTeX

@article{furth2026epigenetic,
  title     = {{Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis}},
  author    = {Furth, Noa and Riemenschneider, Christina and Arieli, Yishai and Avni, Matan and Povolotski, Michael-Yakov and Yung, Hadas and Karagach, Shiri and Atrakchi, Ofir and Erez, Nir and Salame, Tomer-Meir and Noberini, Roberta and Durand, Adeline and Jouault, Gregoire and Dassa, Bareket and Zerbib, Mirie and Oren, Roni and Golani, Ofra and Bar-Zakai, Barak and Mavor, Yael and Friedman-Eldar, Orli and Sfarad, Hadas Kadar and Gilron, Shani and Madhala, Osnat Givon and Ronel, Naama and Abu-Rmilah, Faisal and Moshe, Itai and Ish-Shalom, Shahar and Yosepovich, Ady and Kaplan, Miriam and Bakalenik, Michal and others},
  journal   = {Nature},
  year      = {2026},
  doi       = {10.1038/s41586-026-11230-y},
  url       = {https://doi.org/10.1038/s41586-026-11230-y}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation

  • breast cancer
  • intratumoral heterogeneity
  • epigenetic heterogeneity
  • H3K4 methylation
  • H3K4 trimethylation
  • DNA methylation
  • single-cell epigenomics
  • liquid biopsy

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Furth, N., Riemenschneider, C., Arieli, Y., Avni, M., Povolotski, M.-Y., Yung, H., Karagach, S., Atrakchi, O., Erez, N., Salame, T.-M., Noberini, R., Durand, A., Jouault, G., Dassa, B., Zerbib, M., Oren, R., Golani, O., Bar-Zakai, B., Mavor, Y., . . . Shema, E. (2026). Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis. Nature. https://doi.org/10.1038/s41586-026-11230-y

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature: sign in and open the PDF from this page.

Who wrote this paper?

Noa Furth, Christina Riemenschneider, Yishai Arieli, Matan Avni, Michael-Yakov Povolotski, Hadas Yung, Shiri Karagach, Ofir Atrakchi, Nir Erez, Tomer-Meir Salame, Roberta Noberini, Adeline Durand and 38 more.

What is the DOI of this paper?

10.1038/s41586-026-11230-y, permanently at https://doi.org/10.1038/s41586-026-11230-y. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.